Demis Hassabis raises $2.1 billion for Isomorphic Labs to accelerate AI drug discovery

Demis Hassabis, CEO of Google DeepMind and Isomorphic Labs, discusses the company's new $2.1 billion Series B funding round led by Thrive Capital. The AI drug discovery startup aims to 'turbocharge' its next phase of development, with Hassabis working intensely (often until 4 AM)